EP2408758 - CRYSTALLINE TRIPEPTIDE EPOXY KETONE PROTEASE INHIBITORS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 28.08.2015 Database last updated on 31.08.2024 | Most recent event Tooltip | 28.08.2015 | No opposition filed within time limit | published on 30.09.2015 [2015/40] | Applicant(s) | For all designated states Onyx Therapeutics, Inc. 249 E. Grand Avenue South San Francisco, CA 94080 / US | [2014/43] |
Former [2012/04] | For all designated states Onyx Therapeutics, Inc. 249 E. Grand Avenue South San Francisco, CA 94080 / US | Inventor(s) | 01 /
PHIASIVONGSA, Pasit 2712 Saint Regis Avenue Brentwood CA 94513 / US | 02 /
SEHL, Louis, C. 403 Alameda de la Pulgas Redwood City CA 94062 / US | [2012/04] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [N/P] |
Former [2014/02] | HOFFMANN EITLE Patent- und Rechtsanwälte Arabellastrasse 4 81925 München / DE | ||
Former [2012/04] | Coehn, Markus Fish & Richardson P.C. Mies-van-der-Rohe-Strasse 8 80807 München / DE | Application number, filing date | 10754225.0 | 22.03.2010 | WO2010US28126 | Priority number, date | US20090180561P | 22.05.2009 Original published format: US 180561 P | US20090162196P | 20.03.2009 Original published format: US 162196 P | [2012/04] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2010108172 | Date: | 23.09.2010 | Language: | EN | [2010/38] | Type: | A1 Application with search report | No.: | EP2408758 | Date: | 25.01.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.09.2010 takes the place of the publication of the European patent application. | [2012/04] | Type: | B1 Patent specification | No.: | EP2408758 | Date: | 22.10.2014 | Language: | EN | [2014/43] | Search report(s) | International search report - published on: | AU | 23.09.2010 | (Supplementary) European search report - dispatched on: | EP | 03.08.2012 | Classification | IPC: | A61K38/55, C07K5/08, C07D417/12 | [2012/36] | CPC: |
A61K31/427 (EP,US);
C07D417/12 (EP,KR,US);
C07K5/0802 (US);
A61P19/08 (EP);
A61P19/10 (EP);
A61P25/28 (EP);
A61P29/00 (EP);
A61P31/00 (EP);
A61P31/04 (EP);
A61P31/12 (EP);
A61P33/00 (EP);
A61P35/00 (EP);
A61P35/02 (EP);
A61P37/00 (EP);
A61P37/02 (EP);
A61P37/06 (EP);
A61P37/08 (EP);
A61P43/00 (EP);
A61P7/00 (EP);
A61P9/10 (EP);
C07D277/56 (KR);
C07K1/026 (KR,US);
C07K5/0804 (KR);
C07K5/0821 (KR,US);
Y02A50/30 (EP,US)
(-)
|
Former IPC [2012/04] | C07D277/56, A61K38/55, C07K5/08 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/04] | Extension states | AL | 18.10.2011 | BA | 18.10.2011 | RS | 18.10.2011 | Title | German: | KRISTALLINE TRIPEPTID-EPOXIDKETON-PROTEASEHEMMER | [2012/04] | English: | CRYSTALLINE TRIPEPTIDE EPOXY KETONE PROTEASE INHIBITORS | [2012/04] | French: | INHIBITEURS DE TRIPEPTIDE ÉPOXY CÉTONE PROTÉASES CRISTALLINES | [2012/04] | Entry into regional phase | 18.10.2011 | National basic fee paid | 18.10.2011 | Search fee paid | 18.10.2011 | Designation fee(s) paid | 18.10.2011 | Examination fee paid | Examination procedure | 18.10.2011 | Examination requested [2012/04] | 27.02.2013 | Amendment by applicant (claims and/or description) | 26.06.2013 | Despatch of a communication from the examining division (Time limit: M04) | 16.10.2013 | Reply to a communication from the examining division | 21.05.2014 | Communication of intention to grant the patent | 03.09.2014 | Fee for grant paid | 03.09.2014 | Fee for publishing/printing paid | 03.09.2014 | Receipt of the translation of the claim(s) | Divisional application(s) | EP14178725.9 / EP2813241 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 26.06.2013 | Opposition(s) | 23.07.2015 | No opposition filed within time limit [2015/40] | Fees paid | Renewal fee | 26.03.2012 | Renewal fee patent year 03 | 27.03.2013 | Renewal fee patent year 04 | 27.03.2014 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [ ] - No further relevant documents disclosed | International search | [X]WO2008140782 (PROTEOLIX INC [US], et al); | [XP]WO2009045497 (PROTEOLIX INC [US], et al); | [A] - GROLL M ET AL., "Crystal Structure of Epoxomicin:20S Proteasome Reveals a Molecular Basis for Selectivity of alpha', beta'-Epoxyketone Proteasome Inhibitors", J. AM. CHEM. SOC., (2000), vol. 122, pages 1237 - 1238, XP008128036 DOI: http://dx.doi.org/10.1021/ja993588m | [XP] - ZHOU HJ ET AL., "Design and Synthesis of an Orally Bioavailable and Selective Peptide Epoxyketone Proteasome Inhibitor (PR-047)", J. MED. CHEM., (2009), vol. 52, pages 3028 - 3038, XP055086446 DOI: http://dx.doi.org/10.1021/jm801329v | [A] - "2.20 Recrystallisation Techniques", VOGEL'S TEXTBOOK OF PRACTICAL ORGANIC CHEMISTRY, vol. 5TH, pages 135 1 - 153, XP008166193 | [A] - CAIRA, "Crystalline Polymorphism of Organic Compounds", TOPICS IN CURRENT CHEMISTRY, (1998), vol. 198, pages 163 - 208, XP008166276 DOI: http://dx.doi.org/10.1007/3-540-69178-2_5 | by applicant | - CAIRA ET AL., TOPICS IN CURRENT CHEMISTRY, (1998), vol. 198, pages 163 - 208 | - Vogel's Textbook of Practical Organic Chemistry, vol. 5, page 135,141 |